The Rising Bar: How U.S. Regulatory Pharmacy Requirements Impact Early Phase Clinical Pharmacology Studies
This webinar will provide attendees with information regarding drug product needs when entering early phase clinical studies. The differences between Current Good Manufacturing Practices (cGMP) and extemporaneous pharmaceutical compounding will be discussed, focusing on clinical development efficiencies gained by utilizing on-site pharmaceutical compounding.
The webinar will also highlight emerging US regulatory requirements for compounded drug preparations and handling of hazardous drugs. In addition, attendees will be provided an overview of Celerion Pharmacy Services, including recent and ongoing renovations, which are an integral part of Celerion Early Phase Service offerings that continue to make Celerion the premier provider of early drug development solutions.